< p > <大胆>背景:< /大胆>肉桂香料用于烹饪和大量的医疗补降糖和降脂属性。肉桂的抗糖尿病作用的潜在药理机制及其活性成分没有被充分确定。目前的荟萃分析旨在系统地审查潜在药理机制的降糖和降血脂药疗效肉桂管理和总结临床建议肉桂及其活性成分。< / p > < p > <大胆>方法:< /大胆>相关随机临床试验(相关的)通过文献检索发现,2005年1月至2022年4月。科学检索电子数据库包括Web, PubMed、Medline、Embase,和Cochrane图书馆。获得标准化意味着差异(smd),连续结果汇集和95%置信区间(CIs)。分类结果聚合计算相对风险(RRs)和CIs的陪同下95%。异质性测量使用Cochrane Q-test我<一口> 2 < /一口>统计,与<斜体> p < /斜体> & lt;0.05视为实质性的异质性。如果我2 <一口> < /一口>是不到50%,采用固定效应模型;否则,使用随机效应模型。 Subgroup analyses and sensitivity analyses were performed to identify the origins of heterogeneity. Publication bias was retrieved by means of a funnel-plot analysis and Egger’s test. The data were analyzed using revman (V.5.3) and stata (V.15) software packages.Results: These 16 RCTs included a total of 1,020 patients who were followed for a duration ranging from 40 days to 4 months. According to the current meta-analysis results, glycolipid levels in diabetic individuals who received cinnamon were significantly improved as compared to those who got placebo (All p < 0.05). An adverse effect was only detected in one patient.
Conclusion: These findings imply that cinnamon has a significant influence on lipid and glucose metabolism regulation. An even more pronounced effect was observed in patients with HbA1c of 8%. The results of this study suggested that cinnamon may be utilized as hypoglycemic and lipid-lowering supplement in clinical settings with a guaranteed safety profile.Systematic Review Registration: [PROSPERO], identifier [CRD42022322735].